(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 2.7% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Dentsply Sirona's revenue in 2024 is $3,965,000,000.On average, 9 Wall Street analysts forecast XRAY's revenue for 2024 to be $827,661,277,932, with the lowest XRAY revenue forecast at $825,492,465,428, and the highest XRAY revenue forecast at $832,231,771,898. On average, 9 Wall Street analysts forecast XRAY's revenue for 2025 to be $857,933,827,869, with the lowest XRAY revenue forecast at $847,410,763,702, and the highest XRAY revenue forecast at $870,386,614,682.
In 2026, XRAY is forecast to generate $891,598,633,638 in revenue, with the lowest revenue forecast at $877,146,657,480 and the highest revenue forecast at $912,813,140,952.